You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
|
|---|---|
| Published in |
Journal of Clinical Oncology, July 2020
|
| DOI | 10.1200/jco.20.01342 |
| Pubmed ID | |
| Authors |
Carlos A Ramos, Natalie S Grover, Anne W Beaven, Premal D Lulla, Meng-Fen Wu, Anastasia Ivanova, Tao Wang, Thomas C Shea, Cliona M Rooney, Christopher Dittus, Steven I Park, Adrian P Gee, Paul W Eldridge, Kathryn L McKay, Birju Mehta, Catherine J Cheng, Faith B Buchanan, Bambi J Grilley, Kaitlin Morrison, Malcolm K Brenner, Jonathan S Serody, Gianpietro Dotti, Helen E Heslop, Barbara Savoldo |
X Demographics
The data shown below were collected from the profiles of 161 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 51 | 32% |
| Spain | 23 | 14% |
| United Kingdom | 6 | 4% |
| India | 5 | 3% |
| Germany | 4 | 2% |
| France | 4 | 2% |
| Brazil | 4 | 2% |
| Saudi Arabia | 4 | 2% |
| Peru | 2 | 1% |
| Other | 15 | 9% |
| Unknown | 43 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 97 | 60% |
| Scientists | 33 | 20% |
| Practitioners (doctors, other healthcare professionals) | 26 | 16% |
| Science communicators (journalists, bloggers, editors) | 5 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 213 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 213 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 12% |
| Student > Bachelor | 20 | 9% |
| Student > Ph. D. Student | 19 | 9% |
| Other | 19 | 9% |
| Student > Master | 14 | 7% |
| Other | 42 | 20% |
| Unknown | 74 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 30% |
| Biochemistry, Genetics and Molecular Biology | 24 | 11% |
| Immunology and Microbiology | 13 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Unspecified | 6 | 3% |
| Other | 19 | 9% |
| Unknown | 80 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 375. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2023.
All research outputs
#85,167
of 25,791,495 outputs
Outputs from Journal of Clinical Oncology
#171
of 22,252 outputs
Outputs of similar age
#2,970
of 430,500 outputs
Outputs of similar age from Journal of Clinical Oncology
#1
of 128 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,252 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.